Mks Inc
3 nominees · 6 ballot items.
Election of three directors; approval of Amended and Restated 2022 Stock Incentive Plan; advisory vote on executive compensation; ratification of PwC as independent auditor; advisory vote to reduce special meeting threshold to 25% (company); consideration of shareholder proposal to reduce special meeting threshold to 10% (Chevedden).
Follow how the vote landed and what changed on Mks Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot6
- 1
Election of Directors
ManagementBoard: FORElect three directors (Peter J. Cannone III, Joseph B. Donahue, Wissam G. Jabre) each for one-year terms.
- 2
Approval of Amended and Restated 2022 Stock Incentive Plan
ManagementBoard: FORApprove increase in share reserve by 6,200,000 shares and restatement reflecting company name change; other terms unchanged.
More detail
The proposal asks shareholders to approve an amendment and restatement of the 2022 Stock Incentive Plan to increase the share reserve from 6,200,274 to 12,400,274 shares and update the company name. Management seeks approval to ensure sufficient equity award capacity to attract, retain and motivate employees and to continue historic grant practices. The plan preserves governance safeguards (no repricing without shareholder approval, no discounted options, fungible share counting with 1.91 ratio for full-value awards, limit on non-employee director compensation, performance-based awards, etc.). The Board’s recommendation is FOR, arguing that without approval the company may be constrained in granting equity at levels management believes necessary. The Board considered historical grant rates, proxy advisor guidelines, and modeling of overhang and burn rate and concluded the requested increase supports long-term talent and retention; shareholders should weigh dilution (estimated overhang rising from 5% to 14% assuming full-value grants) against benefits of continued equity-based incentives.
- 3
Advisory Vote on Executive Compensation
ManagementBoard: FORNon-binding, advisory approval of named executive officers' compensation as disclosed in the proxy (say-on-pay).
More detail
The proposal requests a non-binding advisory approval of the Named Executive Officers’ compensation as disclosed. Management presents its compensation framework—mix of base salary, annual cash incentives tied to non-GAAP operating income and adjusted net debt, and long-term RSUs tied to Adjusted EBITDA and rTSR—arguing it aligns pay with performance and market practices. The Board recommends FOR, citing strong prior shareholder support and governance measures (clawback policy, stock ownership guidelines, independent compensation committee and consultant). The advisory vote is not binding but will inform Compensation Committee decisions.
- 4
Ratification of Selection of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2026.
- 5
Advisory Vote on Company Proposal to Reduce the Special Meeting Threshold to 25%
ManagementBoard: FORAdvisory vote in favor of Company's proposal to amend By-Laws to lower shareholder threshold to call special meeting from 40% to 25%.
More detail
The non-binding proposal asks shareholders to support a by-law amendment lowering the ownership threshold to call a special meeting from 40% to 25%. Management frames this as balancing shareholder rights with protection against minority misuse and operational disruption; it cites benchmarking showing 25% is common among S&P 500 peers. The Board recommends FOR, arguing 25% ensures meetings are extraordinary and avoids costs and distractions. The proposal is advisory only and would require subsequent action to implement; it is presented alongside a shareholder proposal (Proposal 6) seeking 10%.
- 6
Shareholder Proposal to Reduce the Special Meeting Threshold to 10%
Shareholder — John CheveddenBoard: AGAINSTShareholder proposal from John Chevedden requesting By-Law amendment to allow shareholders owning 10% to call a special shareholder meeting.
More detail
The shareholder proposal, submitted by John Chevedden, requests the company amend governing documents to allow owners of 10% of outstanding common stock to call a special shareholder meeting, arguing enhanced accountability and remedying alleged long-term stock underperformance and financial risks. The proponent contends 10% thresholds are common and rarely used, and highlights debt levels, DCF valuation concerns, and market softness to justify urgency. Management opposes, recommending a 25% threshold as a balanced alternative, arguing 10% risks abuse by small groups, imposes costs and distractions, and is unnecessary given the Company’s proposal to lower the threshold to 25%; the Board’s opposition statement details governance practices and the reasons for recommending a vote AGAINST. In assessing the merits, analysts should weigh shareholder accountability benefits against risks of minority-driven disruptions, potential for increased costs, and whether existing governance mechanisms and proposed 25% compromise adequately protect shareholders.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.5% | 3,685,493 | $847M |
| 2 | BlackRock, Inc. | 5.4% | 3,629,092 | $834M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 3,014,201 | $693M |
| 4 | Invesco Ltd. | 4.3% | 2,887,412 | $664M |
| 5 | STATE STREET CORP | 3.0% | 2,057,732 | $473M |
| 6 | BlackRock, Inc. | 2.9% | 1,975,528 | $454M |
| 7 | Capital International Investors | 2.9% | 1,968,770 | $452M |
| 8 | JPMORGAN CHASE CO | 2.8% | 1,914,916 | $403M |
| 9 | FMR LLC | 2.4% | 1,651,104 | $379M |
| 10 | Point72 Asset Management, L.P.Activist | 2.4% | 1,610,331 | $370M |
Other Technology sector meetings6
Upcoming shareholder meetings at Mks Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Mks Inc 2026 annual meeting?
- Mks Inc (MKSI) holds its 2026 annual shareholder meeting on Monday, May 11, 2026.
- What is the record date for the Mks Inc 2026 meeting?
- The record date for the Mks Inc 2026 meeting is Tuesday, March 3, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Mks Inc's 2026 meeting?
- The board is presenting 3 director nominees at the Mks Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Mks Inc 2026 meeting?
- Shareholders will vote on 6 proposals at the Mks Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.